pMMR

7 registered clinical trials studyying pMMR — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	IMMUNOTHERAPY EFFICACY TARGETING ENDOMETRIAL CANCER NCT07374809	European Institute of Oncology	N/A
Recruiting	SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases NCT06850103	First Affiliated Hospital of Zhejiang University	Phase 2
Terminated	RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC NCT05733611	Replimune, Inc.	Phase 2
Recruiting	Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer NCT05731726	Zhejiang University	Phase 2
Unknown	Study to Evaluate Efficacy and Safety of Selective Internal Radiation Therapy Plus Xelox, Bevacizumab and Atez NCT04659382	Federation Francophone de Cancerologie Digestive	Phase 2
Unknown	QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer NCT04527068	Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 2
Unknown	Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mism NCT04483219	China Medical University, China	Phase 2